Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Australian Respiratory and Sleep Medicine Institute (ARSM) is a specialized clinical research organization and medical institute based in New South Wales, Australia. The institute focuses on conducting Phase 1 through Phase 4 clinical trials for respiratory and sleep-related disorders, including asthma, COPD, and sleep apnea. ARSM provides comprehensive clinical trial management services, including patient recruitment, data collection, and regulatory compliance. By partnering with global pharmaceutical and biotechnology companies, the institute facilitates the development of novel therapies and diagnostic tools. Their facilities are equipped with advanced diagnostic technology for pulmonary function testing and sleep studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Australian Respiratory and Sleep Medicine Institute.